Table 4.
Treatment | n (percentage) |
---|---|
Antiviral | 53 (100%) |
Antibacterial | 25 (47.2%) |
Systemic corticosteroid | 12 (22.6%) |
Human γ-immunoglobulin | 12 (22.6%) |
Respiratory support | 48 (90.5%) |
Nasal cannula | 12 (22.6%) |
Non-invasive ventilation | 32 (60.4%) |
Improved and discharged | 53 (100%) |
Inpatient treatment | 53 (100%) |
Death | 0 (0%) |
Values are numbers (percentage).